Resistance of shigellae to ampicillin and other antibiotics. Its clinical and epidemiological implications.
D000667:Ampicillin / Q000494:pharmacology*; D000900:Anti-Bacterial Agents / Q000494:pharmacology*; D002228:Carbenicillin / Q000494:pharmacology; D002509:Cephaloridine / Q000494:pharmacology; D002701:Chloramphenicol / Q000494:pharmacology; D003091:Colistin / Q000494:pharmacology; D004096:Dihydrostreptomycin Sulfate / Q000494:pharmacology; D004219:District of Columbia; D007612:Kanamycin / Q000494:pharmacology; D008722:Methods; D008826:Microbial Sensitivity Tests; D010403:Penicillin Resistance; D012760:Shigella / Q000187:drug effects* / Q000302:isolation & purification; D012761:Shigella boydii / Q000187:drug effects; D012762:Shigella dysenteriae / Q000187:drug effects; D012763:Shigella flexneri / Q000187:drug effects; D012764:Shigella sonnei / Q000187:drug effects; D013431:Sulfates / Q000494:pharmacology; D013752:Tetracycline / Q000494:pharmacology
D000900:Anti-Bacterial Agents; D013431:Sulfates; D007612:Kanamycin; D002701:Chloramphenicol; D000667:Ampicillin; D013752:Tetracycline; D002228:Carbenicillin; D002509:Cephaloridine; D004096:Dihydrostreptomycin Sulfate; D003091:Colistin